Subscription business model

Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023

Retrieved on: 
Monday, September 11, 2023
CFA, Privacy and Civil Liberties Oversight Board report on mass surveillance, DME, Diabetic retinopathy, Atlas, Paratriathlon, Prospectus, Loan agreement, Subscription business model, Patient, Brussels Stock Exchange, Convertible, Issuer, Loan, Disease, Security (finance), Credit

Atlas has agreed to waive the market capitalization and liquidity conditions for up to €3.5 million in mandatorily convertible bonds.

Key Points: 
  • Atlas has agreed to waive the market capitalization and liquidity conditions for up to €3.5 million in mandatorily convertible bonds.
  • The amount of the monthly payments, which will be made mid-month, shall not be reduced; rather, the Loan Agreement shall be repaid more quickly.
  • Tom Graney, CFA, CEO of Oxurion, said: “We greatly appreciate the vote of confidence that our partners, Atlas and Kreos/Pontifax, have shown Oxurion through these financial commitments enabling Oxurion to progress the Phase 2, Part B KALAHARI trial of THR-149 in Diabetic Macular Edema (DME), to the topline results later this year.
  • We are eager to share the expected topline data from the KALAHARI trial of THR-149, which holds the exciting potential of addressing this large unmet need and attractive market later this year.”

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Retrieved on: 
Thursday, September 7, 2023
Agreement, Capital commitment, Cayman, Term Asset-Backed Securities Loan Facility, Atlas, Disclosure, USD, EUR, Subscription business model, SRS, Brussels Stock Exchange, Capital, Security (finance), Limited

Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase.

Key Points: 
  • Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase.
  • This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.
  • Following completion of the capital increase through the conversion of the convertible bonds, the total number of shares issued by Oxurion amounts to 2,551,311,977 outstanding ordinary shares carrying voting rights (compared to 2,444,979,274 outstanding ordinary shares previously).
  • This number will be used as the denominator for the calculation of the percentages of shareholdings.

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Retrieved on: 
Friday, September 1, 2023
Agreement, Capital commitment, Cayman, Term Asset-Backed Securities Loan Facility, Atlas, Disclosure, USD, EUR, Subscription business model, SRS, Brussels Stock Exchange, Capital, Security (finance), Limited

Atlas Special Opportunities, LLC has converted 10 convertible bonds in Oxurion resulting in a EUR 250,000 capital increase.

Key Points: 
  • Atlas Special Opportunities, LLC has converted 10 convertible bonds in Oxurion resulting in a EUR 250,000 capital increase.
  • This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.
  • Following completion of the capital increase through the conversion of the convertible bonds, the total number of shares issued by Oxurion amounts to 2,444,979,274 outstanding ordinary shares carrying voting rights (compared to 2,278,608,378 outstanding ordinary shares previously).
  • This number will be used as the denominator for the calculation of the percentages of shareholdings.

IntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partner for Approximate Aggregate Gross Proceeds of US$3 Million (Including US$750,000 to be Received by the Company Once Shareholder Approvals Have Been Obtaine

Retrieved on: 
Thursday, August 31, 2023
Call option, Acquisition, Used note, Toronto Stock Exchange, Loan, Loan agreement, Second, Minority, IGX, Related, Customary international law, National instrument, Offering, Useful conversions and formulas for air dispersion modeling, TSX, Security (finance), Multilateral, Bankruptcy, Exercise, Constitutional right, Condition subsequent, Berlin, Call, Government patent use (United States), MI, Option style, CDN, Shareholder, Sale, Initial, Subscription business model, Life insurance, Unit, Share (finance), Warrant, Note, Corporation

atai, a significant shareholder and partner of the Company, subscribed, on the date hereof, for 2,220 US Units for aggregate gross proceeds to the Company of US$2,220,000 (the “Initial atai Proceeds”).

Key Points: 
  • atai, a significant shareholder and partner of the Company, subscribed, on the date hereof, for 2,220 US Units for aggregate gross proceeds to the Company of US$2,220,000 (the “Initial atai Proceeds”).
  • The Corporation will seek to obtain the Shareholder Approvals at an upcoming special meeting of Shareholders to be held as soon as practicable after the date hereof.
  • An early warning report will be filed under the Company’s profile on the SEDAR+ website at www.sedarplus.ca.
  • This press release does not constitute an offer of securities for sale in the United States.

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Retrieved on: 
Friday, August 25, 2023
Agreement, Capital commitment, Cayman, Term Asset-Backed Securities Loan Facility, Atlas, Disclosure, USD, EUR, Subscription business model, SRS, Brussels Stock Exchange, Capital, Security (finance), Limited

Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase.

Key Points: 
  • Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase.
  • This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.
  • Following completion of the capital increase through the conversion of the convertible bonds, the total number of shares issued by Oxurion amounts to 2,278,608,378 outstanding ordinary shares carrying voting rights (compared to 2,153,190,318 outstanding ordinary shares previously).
  • This number will be used as the denominator for the calculation of the percentages of shareholdings.

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Retrieved on: 
Wednesday, August 23, 2023
Agreement, Capital commitment, Cayman, Term Asset-Backed Securities Loan Facility, Atlas, Disclosure, USD, EUR, Subscription business model, SRS, Brussels Stock Exchange, Capital, Security (finance), Limited

Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase.

Key Points: 
  • Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase.
  • This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.
  • Following completion of the capital increase through the conversion of the convertible bonds, the total number of shares issued by Oxurion amounts to 2,153,190,318 outstanding ordinary shares carrying voting rights (compared to 2,030,138,637 outstanding ordinary shares previously).
  • This number will be used as the denominator for the calculation of the percentages of shareholdings.

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Retrieved on: 
Monday, August 21, 2023
Agreement, Capital commitment, Cayman, Term Asset-Backed Securities Loan Facility, Atlas, Disclosure, USD, EUR, Subscription business model, SRS, Brussels Stock Exchange, Capital, Security (finance), Limited

Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase.

Key Points: 
  • Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase.
  • This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.
  • Following completion of the capital increase through the conversion of the convertible bonds, the total number of shares issued by Oxurion amounts to 2,030,138,637 outstanding ordinary shares carrying voting rights (compared to 1,937,849,876 outstanding ordinary shares previously).
  • This number will be used as the denominator for the calculation of the percentages of shareholdings.

Aptean Expands ERP Offerings for Beverage Companies in Germany with the Acquisition of Best Practice IT Solutions GmbH

Retrieved on: 
Wednesday, August 16, 2023
Software as a service, Tax, Best practice, Subscription business model, Acquisition, GM, MD, Food, Software, Risk management

The acquisition of Best Practice IT Solutions expands Aptean’s Food & Beverage ERP capabilities with added features and expertise to support beverage companies.

Key Points: 
  • The acquisition of Best Practice IT Solutions expands Aptean’s Food & Beverage ERP capabilities with added features and expertise to support beverage companies.
  • “We’re excited to welcome Best Practice IT Solutions’ talented team to Aptean,” said Duane George, GM, EMEA and APAC, at Aptean.
  • “Best Practice IT Solutions’ cloud-based software will complement Aptean’s current Food & Beverage ERP offering and enhance our ability to serve beverage companies.”
    “Aptean’s shares Best Practice IT Solutions’ passion for innovation and focus on supporting customers with industry specific solutions,” said Arne Körnich, MD at Best Practice IT Solutions.
  • As part of Aptean, Best Practice IT Solutions will have access to a broader set of solutions to support our customers on their digital transformation journey.”

INX Closes Initial Investment Phase with Republic; Partnership Set to Deepen and Accelerate

Retrieved on: 
Friday, August 18, 2023
Bitcoin, Ethereum, Minority, MI, ATS, INX, OTCQB, Subscription business model, MD, FX, WCL, Growth, Collaboration, Multilateral, NEO, Security (finance), Cryptocurrency, Republic

TORONTO, Aug. 18, 2023 /PRNewswire/ -- The INX Digital Company, Inc. (NEO: INXD, INXATS: INX, OTCQB: INXDF) ("INX"), a US-regulated broker-dealer, ATS, and transfer agent (via its wholly owned subsidiaries), announced today the successful closing of the initial investment by OpenDeal Inc. (dba Republic) ("Republic"), pursuant to the Subscription Agreement between INX and Republic dated June 15, 2023. Republic, a global financial firm operating a digital merchant bank and a network of investment platforms, has officially acquired 9.5% of INX's issued and outstanding shares with a US$5.25 million investment which will be paid to INX in combination of cash and Preferred B Shares of Republic, reflecting a pre-money valuation for INX of approximately US$50 million.

Key Points: 
  • "This is more than just a business investment; it's an investment in the future, which begins with a deep-rooted collaboration to reshape the global financial landscape.
  • Having successfully integrated Republic's initial investment, we are now looking forward to jointly harnessing our expertise to push the boundaries of what's possible in the digital economy," remarked Shy Datika, INX CEO.
  • Echoing this sentiment, Kendrick Nguyen, CEO of Republic, expressed, "Our initial investment in INX is just the starting point.
  • INX has engaged Weild Capital, LLC ("WCL") to act as its financial advisor, including in connection with the Republic investment.

INX Closes Initial Investment Phase with Republic; Partnership Set to Deepen and Accelerate

Retrieved on: 
Friday, August 18, 2023
Bitcoin, Ethereum, Minority, MI, ATS, INX, OTCQB, Subscription business model, MD, FX, WCL, Growth, Collaboration, Multilateral, NEO, Security (finance), Cryptocurrency, Republic

TORONTO, Aug. 18, 2023 /PRNewswire/ -- The INX Digital Company, Inc. (NEO: INXD, INXATS: INX, OTCQB: INXDF) ("INX"), a US-regulated broker-dealer, ATS, and transfer agent (via its wholly owned subsidiaries), announced today the successful closing of the initial investment by OpenDeal Inc. (dba Republic) ("Republic"), pursuant to the Subscription Agreement between INX and Republic dated June 15, 2023. Republic, a global financial firm operating a digital merchant bank and a network of investment platforms, has officially acquired 9.5% of INX's issued and outstanding shares with a US$5.25 million investment which will be paid to INX in combination of cash and Preferred B Shares of Republic, reflecting a pre-money valuation for INX of approximately US$50 million.

Key Points: 
  • "This is more than just a business investment; it's an investment in the future, which begins with a deep-rooted collaboration to reshape the global financial landscape.
  • Having successfully integrated Republic's initial investment, we are now looking forward to jointly harnessing our expertise to push the boundaries of what's possible in the digital economy," remarked Shy Datika, INX CEO.
  • Echoing this sentiment, Kendrick Nguyen, CEO of Republic, expressed, "Our initial investment in INX is just the starting point.
  • INX has engaged Weild Capital, LLC ("WCL") to act as its financial advisor, including in connection with the Republic investment.